Global HIV Diagnosis Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global HIV Diagnosis Market Research Report 2024
HIV Diagnosis are used to detect the presence of the human immunodeficiency virus (HIV), the virus that causes acquired immunodeficiency syndrome (AIDS), in serum, saliva, or urine. Such tests may detect antibodies, antigens, or RNA.
According to MRAResearch’s new survey, global HIV Diagnosis market is projected to reach US$ 5097 million in 2033, increasing from US$ 2792.2 million in 2022, with the CAGR of 8.5% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole HIV Diagnosis market research.
The antibody tests segment is expected to account for the largest share of the market in 2016. This large share can be attributed to high prevalence of HIV/AIDS, increasing awareness about HIV/AIDS, increasing blood donations and advancements, and better offerings from PoC testing.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global HIV Diagnosis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Siemens Healthineers
Roche Diagnostics
Abbott Laboratories
Beckman Coulter
Thermo Fisher
Merck
Becton, Dickinson
Hologic
Abbott
Bio-Rad Laboratories
Segment by Type
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
Diagnostic Laboratories
Hospitals
Blood Banks
Home Care Settings
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The HIV Diagnosis report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global HIV Diagnosis market is projected to reach US$ 5097 million in 2033, increasing from US$ 2792.2 million in 2022, with the CAGR of 8.5% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole HIV Diagnosis market research.
The antibody tests segment is expected to account for the largest share of the market in 2016. This large share can be attributed to high prevalence of HIV/AIDS, increasing awareness about HIV/AIDS, increasing blood donations and advancements, and better offerings from PoC testing.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global HIV Diagnosis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Siemens Healthineers
Roche Diagnostics
Abbott Laboratories
Beckman Coulter
Thermo Fisher
Merck
Becton, Dickinson
Hologic
Abbott
Bio-Rad Laboratories
Segment by Type
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
Segment by Application
Diagnostic Laboratories
Hospitals
Blood Banks
Home Care Settings
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The HIV Diagnosis report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source